The S-100B substudy of the GLUTAMICS trial: Glutamate infusion not associated with sustained elevation of plasma S-100B after coronary surgery

Clinical Nutrition

Volumn 29, Issue 3, 2010, Pages 358-364

  Vidlund, Mårten ^b   Holm, Jonas ^a   Håkanson, Erik ^a   Friberg, Örjan ^b   Sunnermalm, Lena ^b   Vanky, Farkas ^a   Svedjeholm, Rolf ^a  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^b ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Coronary artery bypass surgery; Glutamate; Myocardial protection; Neurological injury; Nutrition; Stroke

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUTAMIC ACID; INSULIN; ORAL ANTIDIABETIC AGENT; PROTEIN S100B; SODIUM CHLORIDE; BIOLOGICAL MARKER; CARDIOTONIC AGENT; NERVE GROWTH FACTOR; PROTEIN S 100;

ACUTE CORONARY SYNDROME; AGED; AORTA CLAMPING; ARTERY CALCIFICATION; ARTERY DISEASE; ARTICLE; BLOOD GLUCOSE MONITORING; BODY MASS; CARDIOPULMONARY BYPASS; CAROTID ARTERY OBSTRUCTION; CEREBROVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CONFUSION; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY SURGERY; DIABETES MELLITUS; FEMALE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; PROTEIN BLOOD LEVEL; RISK FACTOR; SIDE EFFECT; STROKE; AORTA; AORTA DISEASE; BLOOD; CALCINOSIS; CHEMICALLY INDUCED; COMPLICATION; CORONARY ARTERY BYPASS GRAFT; ECHOGRAPHY; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; NEUROTOXICITY SYNDROMES; POSTOPERATIVE COMPLICATION; RANDOMIZED CONTROLLED TRIAL;

AGED; AORTA; AORTIC DISEASES; BIOLOGICAL MARKERS; CALCINOSIS; CARDIOTONIC AGENTS; CONFUSION; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; FEMALE; GLUTAMIC ACID; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; NERVE GROWTH FACTORS; NEUROTOXICITY SYNDROMES; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE PERIOD; S100 PROTEINS; S100 CALCIUM BINDING PROTEIN BETA SUBUNIT;

EID: 77953538614     PISSN: 02615614     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clnu.2009.09.007     Document Type: Article

References (33)

1. Rau E.E., Shine K.I., Gervais A., Douglas A.M., Amos E.C. Enhanced mechanical recovery of anoxic and ischemic myocardium by amino acid perfusion. Am J Physiol 1979, 236:H873-H879.
2. Pisarenko O.I. Mechanisms of myocardial protection by amino acids: facts and hypotheses. Clin Exp Pharm Physiol 1996, 23:627-633.
3. Lazar H.L., Buckberg G.D., Manganaro A.J., Becker H. Myocardial energy replenishment and reversal of ischemic damage by substrate enhancement of secondary blood cardioplegia with amino acids during reperfusion. J Thorac Cardiovasc Surg 1980, 80:350-359.
4. Svedjeholm R., Hakanson E., Vanhanen I. Rationale for metabolic support with amino acids and glucose-insulin-potassium (GIK) in cardiac surgery. Ann Thorac Surg 1995, 59(2 Suppl):S15-S22.
5. Svedjeholm R., Huljebrant I., Hakanson E., Vanhanen I. Glutamate and high-dose glucose-insulin-potassium (GIK) in the treatment of severe cardiac failure after cardiac operations. Ann Thorac Surg 1995, 59(2 Suppl):S23-S30.
6. Svedjeholm R., Vanhanen I., Hakanson E., Joachimsson P.O., Jorfeldt L., Nilsson L. Metabolic and hemodynamic effects of intravenous glutamate infusion early after coronary operations. J Thorac Cardiovasc Surg 1996, 112:1468-1477.
7. Greenamyre J.T., Porter R.H. Anatomy and physiology of glutamate in the CNS. Neurology 1994, 44(11 Suppl. 8):S7-S13.
8. Sacks W., Sacks S., Brebbia D.R., Fleischer A. Cerebral uptake of amino acids in human subjects and rhesus monkeys in vivo. J Neurosci Res 1982, 7:431-436.
9. Daabees T.T., Finkelstein M.W., Stegink L.D., Applebaum A.E. Correlation of glutamate plus aspartate dose, plasma amino acid concentration and neuronal necrosis in infant mice. Food Chem Toxicol 1985, 23:887-893.
10. Fernstrom J.D. Pituitary hormone secretion in normal male humans: acute responses to a large, oral dose of monosodium glutamate. J Nutr 2000, 130(4S Suppl):1053S-1057S.
11. Svedjeholm R., Hakanson E., Szabo Z., Vanky F. Neurological injury after surgery for ischemic heart disease: risk factors, outcome and role of metabolic interventions. Eur J Cardiothorac Surg 2001, 19:611-618.
12. Loop F.D., Higgins T.L., Panda R., Pearce G., Estafanous F.G. Myocardial protection during cardiac operations. Decreased morbidity and lower cost with blood cardioplegia and coronary sinus perfusion. J Thorac Cardiovasc Surg 1992, 104:608-618.
13. Marchi N., Rasmussen P., Kapural M., Fazio V., Kight K., Mayberg M.R., Kanner A., Ayumar B., Albensi B., Cavaglia M., Janigro D. Peripheral markers of brain damage and blood-brain barrier dysfunction. Restor Neurol Neurosci 2003, 21:109-121.
14. Jonsson H. S100B and cardiac surgery: possibilities and limitations. Restor Neurol Neurosci 2003, 21:151-157.
15. Johnsson P., Backstrom M., Bergh C., Jonsson H., Luhrs C., Alling C. Increased S100B in blood after cardiac surgery is a powerful predictor of late mortality. Ann Thorac Surg 2003, 75:162-168.
16. Anderson R.E., Hansson L.O., Nilsson O., Liska J., Settergren G., Vaage J. Increase in serum S100A1-B and S100BB during cardiac surgery arises from extracerebral sources. Ann Thorac Surg 2001, 71:1512-1517.
17. Kleindienst A., Ross Bullock M. A critical analysis of the role of the neurotrophic protein S100B in acute brain injury. J Neurotrauma 2006, 23:1185-1200.
18. Bloomfield S.M., McKinney J., Smith L., Brisman J. Reliability of S100B in predicting severity of central nervous system injury. Neurocrit Care 2007, 6:121-138.
19. Korfias S., Stranjalis G., Papadimitriou A., Psachoulia C., Daskalakis G., Antsaklis A., Sakas D.E. Serum S-100B protein as a biochemical marker of brain injury: a review of current concepts. Curr Med Chem 2006, 13:3719-3731.
20. Falkensammer J., Oldenburg W.A., Hendrzak A.J., Neuhauser B., Pedraza O., Ferman T., Klocker J., Biebl M., Hugl B., Meschia J.F., Hakaim A.G., Brott T.G. Evaluation of subclinical cerebral injury and neuropsychologic function in patients undergoing carotid endarterectomy. Ann Vasc Surg 2008, 22:497-504.
21. Connolly E.S., Winfree C.J., Rampersad A., Sharma R., Mack W.J., Mocco J., Solomon R.A., Todd G., Quest D.O., Stern Y., Heyer E.J. Serum S100B protein levels are correlated with subclinical neurocognitive declines after carotid endarterectomy. Neurosurgery 2001, 49:1076-1082.
22. Farsak B., Gunaydin S., Yorgancioglu C., Zorlutuna Y. Elevated levels of s-100beta correlate with neurocognitive outcome after cardiac surgery. J Cardiovasc Surg (Torino) 2003, 44:31-35.
23. Kimose H.H., Ravkilde J., Helligsö P., Knudsen M.A., Thomassen A.R., Nielsen T.T., Djurhuus J.C. Myocardial loss of glutamate after cold chemical cardioplegia and storage in isolated blood-perfused pig hearts. Thorac Cardiovasc Surg 1993, 41:93-100.
24. Suleiman M.S., Fernando H.C., Dihmis W.C., Hutter J.A., Chapman R.A. A loss of taurine and other amino acids from ventricles of patients undergoing bypass surgery. Br Heart J 1993, 69:241-245.
25. Ueno T., Iguro Y., Yamamoto H., Sakata R., Kakihana Y., Nakamura K. Serial measurement of serum S-100B protein as a marker of cerebral damage after cardiac surgery. Ann Thorac Surg 2003, 75:1892-1897.
26. Jonsson H., Johnsson P., Birch-Iensen M., Alling C., Westaby S., Blomquist S. S100B as a predictor of size and outcome of stroke after cardiac surgery. Ann Thorac Surg 2001, 71:1433-1437.
27. Lund C., Hol P.K., Lundblad R., Fosse E., Sundet K., Tennoe B., Brucher R., Russell D. Comparison of cerebral embolization during off-pump and on-pump coronary artery bypass surgery. Ann Thorac Surg 2003, 76:765-770.
28. Babin-Ebell J., Misoph M., Mullges W., Neukam K., Reese J., Elert O. Intraoperative embolus formation during cardiopulmonary bypass affects the release of S100B. Thorac Cardiovasc Surg 1999, 47:166-169.
29. Brightwell R.E., Sherwood R.A., Athanasiou T., Hamady M., Cheshire N.J. The neurological morbidity of carotid revascularisation: using markers of cellular brain injury to compare CEA and CAS. Eur J Vasc Endovasc Surg 2007, 34:552-560.
30. Stover J.F., Kempski O.S. Glutamate-containing parenteral nutrition doubles plasma glutamate: a risk factor in neurosurgical patients with blood-brain barrier damage?. Crit Care Med 1999, 27:2252-2256.
31. Vanhanen I., Svedjeholm R., Hakanson E., Joachimsson P.O., Jorfeldt L., Nilsson L., Vanky F. Assessment of myocardial glutamate requirements early after coronary artery bypass surgery. Scand Cardiovasc J 1998, 32:145-152.
32. Svedjeholm R., Ekroth R., Joachimsson P.O., Ronquist G., Svensson S., Tyden H. Myocardial uptake of amino acids and other substrates in relation to myocardial oxygen consumption four hours after cardiac operations. J Thorac Cardiovasc Surg 1991, 101:688-694.
33. Pisarenko O.I., Oleynikov O.D., Shulzhenko V.S., Studneva I.M., Ryff I.M., Kapelko V.I. Association of myocardial glutamate and aspartate pool and functional recovery of postischemic heart. Biochem Med Metab Biol 1989, 42:105-117.